Download Timothy W. Olsen, MD, Publications (updated

OLSEN, TW Publications
Update 12-7-2016
AUTHORSHIP
Article
Case Reports
Monographs
Book Chapter
Other
TOTAL
First
30
2
5
12
11
60
Second
8
0
0
2
3
13
Senior
12
2
0
10
1
25
Other
38
0
0
1
4
43
TOTAL
88
4
5
25
19
141
PEER REVIEWED LITERATURE
1.
Olsen TW, Pulido JS, Folk JC, Hyman L, Flaxel CJ, Adelman RA. Retinal and
Ophthalmic Artery Occlusions Preferred Practice Pattern(R). Ophthalmology; e-pub
October, 2016.
2.
Shantha JG, Crozier I, Varkey JB, Kraft CS, Lyon GM 3rd, Mehta AK, Carlson RD, Hill
CE, Kumar G, Debiec MR, Patel PS, Olsen TW, Nussenblatt RB, Martin DF, Stroher U,
Uyeki TM, Ribner BS, Smith JR, Yeh S. Long-term Management of Panuveitis and Iris
Heterochromia in an Ebola Survivor, Ophthalmology; September (e-pub) 2016.
3.
Rothschild MI, Russ R, Brennan KA, Williams CJ, Berrones D, Patel B, MartinezCastellanos MA, Fernandes A, Hubbard GB, Chan RP, Yang Z, Olsen TW. The
Economic Model of Retinopathy of Prematurity (EcROP) Screening and Treatment:
Mexico and the United States. Am J Ophthalmol, 168: 110-21: 2016.
4.
Olsen, TW. Obitiuary: Henry F. Edelhauser, 1937-2015: “A Life with Great Timing,
Skill, and Elegance”. Am J Ophthalmol. March 2016;163:200-201.
5.
Feder RS, Olsen TW, Prum BE, Jr., et al. Comprehensive Adult Medical Eye Evaluation
Preferred Practice Pattern((R)) Guidelines. Ophthalmology 2016;123:P209-36.
6.
Folk JC, Adelman RA, Flaxel CJ, Hyman L, Pulido JS, Olsen TW. Idiopathic Epiretinal
Membrane and Vitreomacular Traction Preferred Practice Pattern((R)) Guidelines.
Ophthalmology 2016;123:P152-81.
7.
Pulido JS, Flaxel CJ, Adelman RA, Hyman L, Folk JC, Olsen TW. Retinal Vein
Occlusions Preferred Practice Pattern((R)) Guidelines. Ophthalmology 2016;123:P182208.
8.
Olsen TW, Bottini AR, Mendoza P, Grossniklaus HE. The Age-Related Macular
Degeneration Complex: Linking Epidemiology and Histopathology using the Minnesota
Grading System (The Inaugural Frederick C. Blodi Lecture). Trans Am Ophthalmol Soc;
113; 1-9; 2015.
9.
Olsen, TW. Invited Editorial: Anti-VEGF Pharmacotherapy as an Alternative to
Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy. JAMA
314:20:2135-6, Nov 24, 2015.
10.
Ryan ME, Rajalakshmi R, Prathiba V, Anjana RM, Ranjani H, Narayana V, Olsen TW,
Mohan V, Ward LA, Lynn MJ, Hendrick AM. Comparison Among Methods of
Retinopathy Assessment (CAMRA) Study: Smartphone, Nonmydriatic, and Mydriatic
Photography. Ophthalmology 2015;122(10):2038-43, October 2015. PMCID:4581972
11.
Olsen TW. Suprachoroidal Drug Delivery: Unique New Observations. Invest Ophthalmol
Vis Sci 2015;56(8):4976, July 2015.
12.
Allen RS, Olsen TW, Sayeed I, Morrison KC, Oumarbaeva Y, Lucaciu I, Boatright J,
Pardue MT, Stein DG. Progesterone treatment in two rat models of ocular ischemia.
Invest Ophthalmol Vis Sci 2015;56(5):2880-91, May 2015. PMCID:26024074
13.
Olsen TW*, Palejwala NV, Lee LB, Bergstrom CS, Yeh S. Chorioretinal folds: associated
disorders and a related maculopathy: Reply. Am J Ophthalmol. July 2014;158:409410.
14.
Olsen TW*, Palejwala NV, Lee LB, Bergstrom CS, Yeh S. Chorioretinal folds: associated
disorders and a related maculopathy. Am J Ophthalmol. May 2014;157(5):1038-1047.
15.
Ardeljan D, Wang Y, Park S, Shen D, Chu XK, Yu CR, Abu-Asab M, Tuo J, Eberhart CG,
Olsen TW, Mullens RF, White G, Wadsworth S, Scaria A, Chan CC: Interleukin-17
Retinotoxicity Is Prevented by Gene Transfer of a Soluble Interleukin-17 Receptor Acting
as a Cytokine Blocker: Implications for Age-Related Macular Degeneration. PloS One
2014, 9(4):e95900.
16.
Mathai G, Rosen D, Melkote S, Olsen T. Tissue Translocation Device for Surgical
Correction of Age-Related Macular Degeneration. J Med Devices. Dec 2013;7(4).
17.
Ho VY, Yeh S, Olsen TW, Bergstrom CS, Yan J, Cribbs BE, Hubbard GB, 3rd. Shortterm outcomes of aflibercept for neovascular age-related macular degeneration in eyes
previously treated with other vascular endothelial growth factor inhibitors. Am J
Ophthalmol. Jul 2013;156(1):23-28 e22.
18.
Fortun JA, Grossniklaus HE, Wabner KA, Dou C, Olsen TW, Hubbard GB, 3rd. The
effect of air tamponade on the ingress of ocular surface pathogens in sutureless
transconjunctival microincisional vitrectomy. Retina. Mar 2013;33(3):566-570.
19.
Lee PP, West SK, Block SS, Clayton J, Cotch MF, Flynn C, Geiss LS, Klein R, Olsen TW,
Owsley C, Primo SA, Rubin GS, Ryskulova A, Sharma S, Friedman DS, Zhang X, Crews
JE, Saaddine JB. Surveillance of Disparities in Vision and Eye Health in the United
States: An Expert Panel's Opinions. Am J Ophthalmol. Dec 2012;154(6 Suppl):S3-7.
20.
Dave HB, Gordillo L, Yang Z, Zhang MS, Hubbard GB, 3rd, Olsen TW*. The Societal
Burden of Blindness Secondary to Retinopathy of Prematurity in Lima, Peru. Am J
Ophthalmol 2012;154:750-755. PMID:22831839
21.
Grinager H, Krason D, Olsen TW*. Lyme Disease: Resolution of a Serous Retinal
Detachment and Chorioretinal Folds after Antibiotic Therapy. Retinal Cases and Brief
Reports 2012;6:232-234.
22.
Jung CS, Payne JF, Bergstrom CS, Cribbs BE, Yan J, Hubbard GB, Olsen TW, Yeh S.
Multimodality diagnostic imaging in unilateral acute idiopathic maculopathy. Arch
Ophthalmol 2012;130:50-6.
23.
Davis J, Olsen TW, Stewart M, Sternberg P Jr. How the Comparison of Age-related Macular
Degeneration Treatments Trial Results Will Impact Clinical Care. Am J Ophthalmol,. 152(4):
p. 509-14, October 2011 (lead article).
24.
Olsen, TW*, Feng X, Wabner K, Csaky K, Pambuccian S, Cameron JD. Pharmacokinetics
of pars plana intravitreal injections versus microcannula suprachoroidal injections of
bevacizumab in a porcine model. Invest Ophthalmol Vis Sci 2011;52:4749-56; PMCID
3175963, June 2011.
25.
Cao X, Shen D, Patel MM, Tuo J, Johnson TM, Olsen TW, Chan CC. Macrophage
polarization in the Macula of Age-Related Macular Degeneration: A Pilot Study. Pathology
International, doi:10.111/j.1440-1827.2011.02695.x; pp 1-5; May 2011.
26.
Olsen TW*, Pribila JT. Pars Plana Vitrectomy with Endoscopic-Guided Sutured Posterior
Chamber Intraocular Lens Implantation in Children and Adults. Am J Ophthalmol
February 2011;151:2;287-296. (Cover Photograph February Journal obtained from this
article).
27.
Payne JF, Keenum DG, Sternberg P Jr., Thliveris A, Kala A, Olsen TW*. Concentrated
Intravitreal Amphotericin B in Fungal Endophthalmitis. Arch Ophthalmol Arch
Ophthalmol 2010;128:1546-1550.
28.
Karunadharma PP, Nordgaard CL, Olsen TW, Ferrington DA. Mitochondrial DNA damage
as a potential mechanism for age-related macular degeneration. Invest Ophthalmol Vis Sci
2010; 51:5470-5479. PMID: 20960615
29.
Edelhauser HF, Rowe-Rendleman CL, Robinson MR, Edelhauser HF, Rowe-Rendleman
CL, Robinson MR, Dawson DG, Chader GJ, Grossniklaus HE, Rittenhouse KD, Wilson
CG, Weber DA, Kuppermann BD, Csaky KG, Olsen TW, Kompella UB, Holers
VM, Hageman GS, Gilger BC, Campochiaro PA, Whitcup SM, Wong WT. Ophthalmic
drug delivery systems for the treatment of retinal diseases: basic research to clinical
applications. Invest Ophthalmol Vis Sci 2010; 51:5403-5420. PMID: 20980702.
30.
Whitcomb JE, Barnett VA, Olsen TW, Barocas VH. Ex Vivo Porcine Iris Stiffening Due to
Drug Stimulation. Exp Eye Rsch. October 2009; 456-61.
31.
Semmer AE, Lee MS, Harrison AR, Olsen TW. Hydroxychloroquine retinopathy screening.
Br J Ophthalmol 2008; 92:1653-5.
32.
Olsen TW*. The Minnesota Grading System Using Fundus Autofluorescence of Eyebank
Eyes: A Correlation to Age-Related Macular Degeneration. Trans Am Ophthalmol Soc
2008; 106:383-401.
33.
Tuo J, Ross RJ, Reed GF, Yan Q, Wang JJ, Bojanowski CM, Chew EY, Feng X, Olsen TW,
Ferris FL III, Mitchell P, Chan CC. The HtrA1 Promoter Polymorphism, Smoking, and Agerelated Macular Degeneration in Multiple Case-control Samples. Ophthalmology,
November 2008; 1891-8.
34.
Nordgaard CL, Karunadharma PP, Feng X, Olsen TW, Ferrington DA. Mitochondrial
proteomics of the retinal pigment epithelium at progressive stages of age-related macular
degeneration. Invest Ophthalmol Vis Sci, July 2008; 2848-55.
35.
Decanini A, Karunadharma PR, Nordgaard CL, Feng X, Olsen TW, Ferrington DA. Human
retinal pigment epithelium proteome changes in early diabetes. Diabetologia, June
2008;51:1051-61
36.
Guifang Z, Feng X, Wabner K, Fandrey C, Naqwi A, Wiedmann T, Olsen TW*. Intraocular
Nanoparticle Drug Delivery: A Pilot Study Using an Aerosol during Pars Plana Vitrectomy.
Invest Ophthalmol Vis Sci 48 (11): 5243-5249, November, 2007.
37.
Olsen TW* Treatment of Exudative Age-related Macular Degeneration: Many Factors to
Consider. Editorial by Invitation. Am J. Ophthalmol, 144 (2): 281-83, August 2007.
38.
Ethen CM, Reilly C, Feng X, Olsen TW, Ferrington DA. Age-related macular degeneration
and retinal protein modification by 4-hydroxy-2-nonenal. Invest Ophthalmol Vis Sci 48
(8): 3469-3479, August 2007.
39.
Schwarzenberg SJ, Thomas W, Olsen TW, et al. Microvascular complications in cystic
fibrosis-related diabetes. Diabetes Care 30:1056-61; May 2007.
40.
Decanini A, Nordgaard CL, Feng X, Ferrington DA, Olsen TW*. Changes in Select Redox
Proteins of the Retinal Pigment Epithelium in Age Related Macular Degeneration. Am J
Ophthalmol, 143(4):607-615, April 2007.
41.
Ethen CM, Hussong SA, Reilly C, Feng X, Olsen TW, Ferrington DA. Transformation of
the Proteosome with Age-related Macular Degeneration. FEBS Lett 581:885-90; Feb. 2007.
42.
Olsen TW*, Feng X, Wabner K, Conston SR, Sierra DH, Folden DV, Smith ME, Cameron
JD. Cannulation of the Suprachoroidal Space: A Novel Drug Delivery Methodology to the
Posterior Segment. Am J Ophthalmol, 142 (5): 777-787, November 2006.
43.
Ethen, CM, Reilly C, Feng X, Olsen TW, Ferrington DA. The Proteome of Central and
Peripheral Retina with Progression of Age-related Macular Degeneration.
Invest
Ophthalmol Vis Sci. 47 (6) pp 2280-90, June 2006.
44.
Kapphahn RJ, Giwa BM, Berg KM, Roehrich H, Feng X, Olsen TW, Ferrington DA. Retinal
Proteins Modified by 4-Hydroxynononeal: Identification of Molecular Targets. Exp Eye
Res 83 (1), pp 165-175; July 2006.
45.
Nordgaard CL, Berg, KM, Kapphahn RJ, Reilly C, Feng X, Olsen TW, Ferrington DA.
Proteomics of the Retinal Pigment Epithelium Reveals Altered Protein Expression at
Progressive Stages of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 47
(3): 815-822, March 2006.
46.
Aizman A, Johnson MW, Olsen TW, Ho AC, Davis JL. Diagnostic and Therapeutic
Challenges. Ed by McDonald HR. Retina 26:3: pp 345-351, March 2006.
47.
Feng X, Pilon K, Yaacobi Y, Olsen TW*. Extraocular Muscle Insertion Relative to the Fovea
and Optic Nerve: Humans and Rhesus Macaque. Invest Ophthalmol Vis Sci. 46(10):
3493-3496, October 2005.
48.
Olsen TW*. Measurements Biomarkers and Interpretation. Editorial by Invitation. Am J.
Ophthalmol, 139 (4): 710-11, April 2005.
49.
Ethen CM, Feng X, Olsen TW, Ferrington DA. Declines in Arrestin and Rhodopsin in the
Macula with Progression of Age-Related Macular Degeneration. Invest Ophthalmol Vis
Sci. 46 (3): 769-775, March 2005.
50.
Simon J, Sood S, Yoon MK, Kaw P, Zobal-Ratner J, Archer S, Gardiner JA, Hutchinson A,
Marcotty A, Noel LP, Olsen TW, Tawansy K, Wallace D. Vitrectomy for Dense Vitreous
Hemorrhage in Infancy. J Ped Ophthalmol and Strab 42(1): 18-22. January/February
2005.
51.
Olsen TW* and Feng X. The Minnesota Grading System of Eyebank Eyes for Age-Related
Macular Degeneration. Invest Ophthalmol Vis Sci. 45 (12): 4484-4490, December 2004.
52.
Olsen TW*. Book Review: Retina and Optic Nerve Imaging. Ciulla TA, Regillo CD, and
Haris A. editors. Arch Ophththalmol; 122(7); 1095, July 2004.
53.
Wu CW, Sauter JL, Johnson PK, Chen C, Olsen TW*. Identification and Localization of
Major Soluble Vitreous Proteins in Human Ocular Tissue. Am J Ophthalmol 137:4;655-61,
April, 2004.
54.
Telander DG, Pambuccian SE, Olsen TW*. Systemic Aspergillus Presenting With Visual
Symptoms. Retina 24:1; 166-168, 2004.
55.
Olsen TW*, Feng X, Kasper TJ, Rath PP, Steuer ER. Fluorescein Angiographic Lesion Type
Frequency in Neovascular Age-Related Macular Degeneration Ophthalmology 111:2; 250255, 2004.
56.
Malik KJ, Chen CD, Olsen TW*. Stability of RNA from the Retina and Retinal Pigment
Epithelium in a Porcine Model Simulating Human Eye-Bank Conditions. Invest Ophthalmol
Vis Sci. 44 (6): 2730-5, 2003.
57.
Olsen TW*, Sanderson S, Feng X, Hubbard WC. Porcine Sclera: Thickness and Surface
Area. Invest Ophthalmol Vis Sci. 43 (8): 2529-32, 2002.
58.
Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS. Treatment of Submacular
Hemorrhage with Low-Dose Intravitreal Tissue Plasminogen Activator Injection and
Pneumatic Displacement. Arch Ophthalmol 119:28-32, 2001.
59.
Beecher DJ, Olsen TW, Somers EB, Wong ACL. Evidence for Contribution of Tripartite
Hemolysin BL, Phasphatidylcholine-Preferring Phospholipase C, and Collagenase to
Virulence of Bacillus cereus Endophthalmitis. Infection & Immunity 68:9, 5269-5276,
September 2000.
60.
Olsen TW, Sternberg P, Capone A, Martin DF, Lim JI, Grossniklaus HE, Aaberg TM.
Macular Hole Surgery Using Thrombin Activated Fibrinogen and Selective Removal of the
Internal Limiting Membrane. [Letter], Retina 19:5; 478-479, 1999.
61.
Olsen TW*, Frayer WC, Myers FL, Davis MD, Albert DM. Idiopathic Reactive Hyperplasia
of the Retinal Pigment Epithelium. Arch Ophthalmol 117:50-54, Jan 1999.
62.
Olsen TW*: Book Review: Laser Surgery of the Posterior Segment. Bloom SM, Brucker
AJ. Arch Ophthalmol; 116 (3); 403, 1998.
63.
Olsen TW, Sternberg P, Capone A, Martin DF, Lim JI, Grossniklaus HE, Aaberg TM.
Macular Hole Surgery Using Thrombin Activated Fibrinogen and Selective Removal of the
Internal Limiting Membrane. Retina 18:4; 322-329, 1998.
64.
Olsen TW*, Aaberg SY, Geroski DH, Edelhauser HF. Human Sclera: Thickness and
Surface Area. Am J Ophthalmol 125:237-241, February 1998.
65.
Olsen TW*, Summers CG. Predicting Visual Acuity in Eyes with Fundus Colobomas: Optic
Nerve Involvement, Size, or the Fovea? (Letter) Ophthalmology 104; 1367-1368, 1997.
66.
Olsen TW*. Visual Acuity in Children with Colobomatous Defects. Current Opinion in
Ophthalmology; 8:III; 63-67, August 1997.
67.
Pieramici DJ, Sternberg P, Aaberg TM, Bridges WZ, Capone A, Cardillo JA, DeJuan E,
Kuhn F, Meredith TA, Mieler WF, Olsen TW, Rubsamen P, Stout T (The Ocular Trauma
Classification Group). A System for Classifying Mechanical Injuries of the Eye (Globe). Am
J Ophthalmol 123; 820-831, June 1997.
68.
Olsen TW*. Submacular Surgery for Age-Related Macular Degeneration.
Ophthalmology 12 (1); 34-44, March 1997.
69.
Olsen TW, Sternberg P Jr., Reed R, Jones DP. A Model for Light Toxicity of Cultured Human
Retinal Pigment Epithelium. Graefes Archive for Clinical & Experimental Ophthalmology
235; 111-117, 1997.
70.
Olsen TW, Capone A Jr., Sternberg P Jr., Grossniklaus HE, Martin DF, Aaberg TM Sr.
Subfoveal Choroidal Neovascular Membranes in Punctate Inner Choroidopathy: Surgical
Management and Pathologic Findings. Ophthalmology 103; 2061-2069, 1996.
Seminars of
71.
Olsen TW*, Lim JI, Grossniklaus HE. Retained Lens Material Masquerading as a Growing
Pigmented Iris Tumor. Arch Ophthalmol 114; 1154-55, 1996. (Cover Photograph of the
September issue used from this Article).
72.
Olsen TW, Sternberg P Jr., Martin DF, Capone A, Lim JI, Aaberg TM Sr. Postoperative
Hypopyon after Intravitreal Bovine Thrombin for Macular Hole Surgery. Am J Ophthalmol
121; 575-577, 1996.
73.
Olsen TW, Summers CG, Knobloch W. Predicting Visual Acuity in Children with Colobomas
Involving the Optic Nerve Colobomas. J Pediatric Ophthalmol Strabismus 33; 47-51, 1996.
74.
Olsen TW, Gothard TW, Holland EJ. Misoprostol and Cyclosporin A Prolong Corneal
Allograft Survival in an Animal Model. Cornea 15(1); 76-81, 1996.
75.
Olsen TW*, Lim JI, Capone A, Myles RA, Gilman JP. Anaphylactic Shock Following
Indocyanine Green Angiography. Arch Ophthalmol 114; 97, 1996.
76.
Olsen TW, Edelhauser HF, Lim JI, Geroski DH. Human Scleral Permeability: Effects of
Age, Cryotherapy, Transscleral Diode Laser, and Surgical Thinning. Invest Ophthalmol Vis
Sci. 36 (9); 1893-1903, August 1995.
77.
Olsen TW Chang TS, Sternberg P, Jr. Retinal Detachments Associated with Blunt Trauma.
Seminars in Ophthalmology 10 (1); 17-27, March 1995.
78.
Olsen TW, Benegas NM, Joplin AC, Evangelista A, Mindrup EA, Holland EJ. Rapamycin
Inhibits Corneal Allograft Rejection and Neovascularization. Arch Ophthalmol 112; 14711475, 1994. Published erratum, 113:144, 1995.
79.
Holland EJ, Olsen TW, Chan CC, Bergstrom L, Palestine AG, Nussenblatt RB. Kinetics of
Corneal Transplant Rejection in the Rat Penetrating Keratoplasty Model. Cornea 13(4); 317323, 1994.
80.
Olsen TW, Hardten DR, Meiusi RS, Holland EJ. Linear Endotheliitis. Am J Ophthalmol
117; 468-474, 1994.
81.
Holland EJ, Olsen TW, Sterrer J, Ketchum JM, Mindrup EA, Gruber SA. Suppression of
Graft Rejection using 15-Deoxyspergualin in the Allogeneic Rat Penetrating Keratoplasty
Model. Cornea 13(1); 28-32, 1994.
82.
Holland EJ, Olsen TW, Ketcham JM, Florine C, Krachmer JH, Purcell JJ, Lam S, Tessler
HH, Sugar J. Topical Cyclosporin A in the Treatment of Anterior Segment Inflammatory
Disease. Cornea 12(5); 413-419, 1993.
SELECTED COLLABORATIVE STUDY PUBLICATIONS
1.
Writing Group for the ARG, Bonds DE, Harrington M, et al. Effect of Long-Chain omega3 Fatty Acids and Lutein + Zeaxanthin Supplements on Cardiovascular Outcomes:
Results of the Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial.
JAMA internal medicine. Mar 17 2014.
2.
Birch DG, Weleber RG, Duncan JL, Jaffe GJ, Tao W, Ciliary Neurotrophic Factor Retinitis
Pigmentosa Study G. Randomized Trial of Ciliary Neurotrophic Factor Delivered by
Encapsulated Cell Intraocular Implants for Retinitis Pigmentosa. Am J Ophthalmol. May
10 2013.
3.
Age-Related Eye Disease Study 2 Research G. Lutein + zeaxanthin and omega-3 fatty
acids for age-related macular degeneration: the Age-Related Eye Disease Study 2
(AREDS2) randomized clinical trial. JAMA. May 15 2013;309(19):2005-2015.
4.
Chew EY, Clemons TE, Agron E, et al. Long-Term Effects of Vitamins C and E, betaCarotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35.
Ophthalmology. Apr 10 2013.
5.
Chew EY, Clemons T, Sangiovanni JP, et al. The Age-Related Eye Disease Study 2
(AREDS2): Study Design and Baseline Characteristics (AREDS2 Report Number 1).
Ophthalmology 2012.
6.
CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related
macular degeneration. NEJM 364(20):1897-1908; 2011.
7.
Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H,
Apte RS, Beck RR, Bressler NM, Browning DJ, Danis RP, Glassman AR, Googe JM,
Kollman C, Lauer AK, Peters MA, Stockman ME. Vitrectomy outcomes in eyes with
diabetic macular edema and vitreomacular traction. Ophthalmology. 2010 Jun; 117 (6)
:1087-1093.e3. PubMed PMID:20299105; PubMed Central PMCID: PMC2911350.
8.
Lindblad AS, Lloyd PC, Clemons TE, Gensler GR, Ferris FL 3rd, Klein ML, Armstrong JR;
Age-Related Eye Disease Study Research Group. Change in area of geographic atrophy in
the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol.
Sep;127(9):1168-74. 2009.
9.
Beck RW, Edwards AR, Aiello LP, et al. Three-year follow-up of a randomized trial
comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic
macular edema. Arch Ophthalmol 2009;127:245-51.
10.
Lindblad AS, Lloyd PC, Clemons TE, Gensler GR, Ferris FL 3rd, Klein ML, Armstrong JR,
Age-Related Eye Disease Study Research Group. Change in area of geographic atrophy in
the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol. 2009
Sep; 127 (9):1168-74. PubMed PMID:19752426.
11.
Diabetic Retinopathy Clinical Research Network. A randomized trial comparing
intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular
edema. Ophthalmology. 2008 Sep; 115 (9) :1447-9, 1449.e1-10. PubMed
PMID:18662829; PubMed Central PMCID: PMC2748264.
12.
The DCCT/EDIC Study Research Group. Long-term Effect of Diabetes and Its Treatment
on Cognitive Function. New England Journal of Medicine. 2007;356;18:1842-52.
13.
Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine
125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
Ophthalmology 2007;114:1363-71.
14.
Relationship between optical coherence tomography-measured central retinal thickness
and visual acuity in diabetic macular edema.
DRCRnet, Ophthalmology March
2007;114:3:525-536.
15.
Fong DS, Strauber SF, Aiello LP, et al. Comparison of the modified Early Treatment
Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for
diabetic macular edema. Arch Ophthalmol 2007;125:469-80.
16.
Anecortave Acetate (15 Milligrams) versus Photodynamic Therap for Treatment of
Subfoveal Neovascularization in Age-Related Macular Degeneration. Slakter JS, Bochow
T, D’Amico DJ, et al. and the Anecortave Acetate Clinical Study Group. Ophthalmology
2006;113:3-13 pp 3-13.
17.
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V.
Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol
2006;124:1684-93.
18.
15-Year Outcomes Following Threshold Retinopathy of Prematurity: Final Results From
the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Cryotherapy for
Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 2005;123:311-318.
19.
Clemons TE, Kurinij N, Sperduto RD. Associations of mortality with ocular disorders and
an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study:
AREDS Report No. 13. Arch Ophthalmol 2004;122:716-726.
20.
Trends in size and treatment of recently diagnosed choroidal melanoma, 1987-1997:
findings from patients examined at collaborative ocular melanoma study (COMS) centers:
COMS report no. 20. Arch Ophthalmol 2003;121:1156-62.
21.
Comparison of clinical, echographic, and histopathological measurements from eyes with
medium-sized choroidal melanoma in the collaborative ocular melanoma study: COMS
report no. 21. Arch Ophthalmol 2003;121:1163-71.
22.
A randomized, placebo-controlled, clinical trial of high-dose supplementation with
vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report
no. 9. Arch Ophthalmol 2001;119:1439-1452.
23.
A randomized, placebo-controlled, clinical trial of high-dose supplementation with
vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision
loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-1436.
24.
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOPROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000;105:295-310.
AAO Monographs
1. Olsen, TW, Adelman RA, Flaxel CJ, Folk JC, Pulido JS, Regillo CD, Hyman L. AgeRelated Macular Degeneration; Retina Preferred Practice Patterns ®; American
Academy of Ophthalmology ®, 2014.
2. Olsen, TW, Adelman RA, Flaxel CJ, Folk JC, Pulido JS, Regillo CD, Hyman L. Diabetic
Retinopathy; Retina Preferred Practice Patterns ®; American Academy of
Ophthalmology ®, 2014.
3. Olsen, TW, Adelman RA, Flaxel CJ, Folk JC, Pulido JS, Regillo CD, Hyman L.
Idiopathic Macular Hole; Retina Preferred Practice Patterns ®; American Academy of
Ophthalmology ®, 2014.
4. Olsen, TW, Adelman RA, Flaxel CJ, Folk JC, Pulido JS, Regillo CD, Hyman L.
Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration; Retina
Preferred Practice Patterns ®; American Academy of Ophthalmology ®, 2014.
5. Olsen, TW, Sippy BD, Atebara NH, Gottlieb JL, Hasan SJ, Solley WA, Suner IJ.
Practicing Ophthalmologists Curriculum (POC) Learning System. Retina/Vitreous ©
American Academy of Ophthalmology; 2014-2016
BOOK CHAPTERS (n=25; ** winner of the British Medical Association Medical Book Award 2016)
1.
** Yamada N, Olsen TW: Routes for Drug Delivery to the Retina: Topical, Transscleral,
Suprachoroidal,
and
Intravitreal
Gas-Phase
Nanoparticles.
Retinal
Pharmacotherapeutics. Animal Models and Routes for Retinal Drug Delivery. Ed: Quan
Dong Nyguyen, Eduardo B. Rodreiques, Michael Farah, William F. Mieler, and Diana V
Do. Dev Ophthalmol. Basel, Karger, vol 55 pp 71-83, DOI: 10.1159/000431193 in 2016.
2.
Payne JF, Hubbard GB, Olsen TW: General Considerations in Opthalmic Surgery. Section
23 Ophthalmic Surgery in Medical Management of the Surgical Patient, A Texbook of
Perioperative Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH;
Cambridge University Press; pp 693-695, 2013.
3.
Shah R, Kim JY, Olsen TW: Cataract Surgery. Section 23 Ophthalmic Surgery in Medical
Management of the Surgical Patient, A Texbook of Perioperative Medicine, 5 th Edition,
Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University Press; pp 696-697,
2013.
4.
McKee Y, Shah R, Kim JY, Olsen TW: Corneal Transplantation. Section 23 Ophthalmic
Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative
Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University
Press; pp 698-700, 2013.
5.
Rahman HT, Hubbard GB, Olsen TW: Vitreoretinal Surgery. Section 23 Ophthalmic
Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative
Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University
Press; pp 700-702, 2013.
6.
Germain BB, Costarides AP, Olsen TW: Glaucoma Surgery. Section 23 Ophthalmic
Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative
Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University
Press; pp 702-704, 2013.
7.
Shah R, McKee Y, Randleman JB, Olsen TW: Refractive Surgery. Section 23 Ophthalmic
Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative
Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University
Press; pp 704-706, 2013.
8.
Couser NL, Hutchinson AK, Olsen TW: Strabismus Surgery. Section 23 Ophthalmic
Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative
Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University
Press; pp 706-708, 2013.
9.
Wells JR, Hubbard GB, Olsen TW: Enucleation, Evisceration, and Exenteration. Section
23 Ophthalmic Surgery in Medical Management of the Surgical Patient, A Texbook of
Perioperative Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH;
Cambridge University Press; pp 708-710, 2013.
10.
Olsen TW: Trauma, in: Clinical Retina. Second Edition, Edited by David A. Quillen and
Barbara Blodi, AMA press, USA (In Press).
11.
Olsen TW, Sippy BD, Atebara NH, Gottlieb JL, Hasan SJ, Solley WA, Suner IJ. Practicing
Opthalmololgists Curriculum: Retina/Vitreous 2011-2013. Academy MOC Essentials.
American Academy of Ophthalmology; pp 1-241, 2011. (Book Author)
12.
Olsen TW and Gilger BC Suprachoroidal and Intrascleral Drug Delivery. Chapter 8 in
Drug Product Development for the Back of the Eye, AAPS Advances in the Pharmaceutical
Sciences Series, American Association of Pharmaceutical Scientists, Springer; pp 173184, 2011.
13.
Charkoudian LD, Olsen TW: Principles and Treatment of Giant Retinal Tears. Section
5; Retinal Surgery, Section Ed Jay S. Duker in Clinical Atlas of Procedures in Ophthalmic
Surgery, 2nd Edition (Oxford Ophthalmology Atlas Series), Ed(s) Daniel M. Albert & Mark
J. Lucarelli; pp 444-451, 2011.
14.
Olsen TW: Routes for Drug Delivery to the Retina: Topical, Transscleral, Suprachoroidal,
and Intravitreal Gas-Phase Nanoparticles. Retinal Pharmacotherapy. Editors Quan Dong
Nyguyen, Eduardo B. Rodreiques, Michael Farah, and William F. Mieler. First Edition.
Saunders Elsevier Ltd. 2010.
15.
Olsen TW: When a Posterior Capsular Tear Occurs During Cataract Surgery, What Next?
Chapter 37, in Curbside Consultation in Retina; Ed. Sharon Fekrat, Assoc. Ed Darius
Moshfeghi, Dean Elliot, Series Ed David F. Chang, SLACK Inc., New Jersey, USA, 2010.
16.
Olsen TW: Retina, (Chapter 10), in: Primary Care Ophthalmology. Edited by Jay H.
Krachmer and David Palay, Mosby, St. Louis, MO; 2nd Edition, pp 149-187; 2005.
17.
Olsen TW: Principles of Giant Retinal Tears and Treatment. Section 4: Retina and
Vitreous Surgery, Section editor, Justin L. Gottlieb, in Clinical Atlas of Procedures in
Ophthalmic Surgery. Edited by Daniel M. Albert and Mark J. Lucarelli. AMA Press, USA,
2004; pp 142-145.
18.
Olsen TW: Scleral Buckling & Pneumatic Retinopexy. Section 4: Retina and Vitreous
Surgery, Section editor, Justin L. Gottlieb, in Clinical Atlas of Procedures in Ophthalmic
Surgery. Edited by Daniel M. Albert and Mark J. Lucarelli. AMA Press, USA, 2004; pp
122-127.
19.
Olsen TW: Trauma, in: Clinical Retina. Edited by David A. Quillen and Barbara Blodi,
AMA press, USA, pp 285-300, 2003.
20.
Olsen TW, Nork TM: Giant Retinal Tears, in: Ophthalmic Surgery: Principles and
Techniques. Edited by Daniel M. Albert and William Mieler, Blackwell, Cambridge,
Massachusetts. Volume I, Part III, Ch. 45, pp 594-605, 1999.
21.
Olsen TW: Principles of Scleral Buckling & Pneumatic Retinopexy, in: Ophthalmic
Surgery: Principles and Techniques. Edited by Daniel M. Albert and William Mieler,
Blackwell, Cambridge, Massachusetts. Volume I, Part III, Ch 41, pp 511-530, 1999.
22.
Kurtz JC, Jones DP, Sternberg P, Wei MW, Olsen TW: Antioxidant functions of
glutathione in human retinal pigment epithelium in relation to age-related macular
degeneration. In Piccolino FC, Coscas G (eds.) Retinal Pigment Epithelium and Macular
Diseases. Kluwer Academic Publishers, 1998, pp. 47-58.
23.
Olsen TW: Common Retinal Disorders, in: Ophthalmology for the Primary Care
Physician. Edited by Jay H. Krachmer and David Palay, Mosby, St. Louis, MO; Ch 9, pp
102-134, 1997.
24.
Watsky MA, Olsen TW, and Edelhauser HF: Cornea and Sclera, in: Duane’s Foundations
of Clinical Ophthalmology. Edited by William Tasman and Edward A. Jaeger, LippincottRaven, Philadelphia-New York; Vol 2, Ch 4, pp 1-29, 1995.
25.
Holland EJ, Olsen TW: Immunosuppression in High Risk Corneal Transplantation, in:
Corneal Surgery, Theory, Technique, and Tissue. Edited by Fredrick S. Brightbill, Mosby,
pp 260-268, 1993.
NON-PEER REVIEWED PUBLICATIONS, COMMENTARY, OPINION
1.
Olsen, TW: Drug Delivery to the Retina, Questions, Thoughts, and Opinions Related to
Current and Emerging Drug Delivery Systems: Special Focus Drug Delivery, September
Issue, 2016.
2.
Olsen TW, Adelman RA, Brown D, Charles S, Mieler W, Boyer D, Warren K. Retina
Clinical Committee responds to “Pearls for YAG vitreolysis of Floaters”. Eye World, Retina
Corner, pp 113. March 2015.
3.
Study Finds Strong Correlation Between Chorioretinal Folds, Systemic Disease.
Commentary by Bob Bronemyer, Ocular Surgery News. August 25, 2014.
4.
Tornambe PE, Singer M, Olsen TW, London N. In cases of symptomatic vitreomacular
adhesion without full-thickness macular hole, do you tend to observe for spontaneous
resolution or treat with Jetrea (ocriplasmin, Thromobogenetics)? Ocular Surgery News,
Survey of 150+ Leading Retina Specialists. October 24, 2013, pp 57.
5.
Olsen TW, Stewart JM, ed Chang DF. AMD Info Every Anterior Segment Specialist
Should Know. EyeWorld; October 2013; pp 104-106.
6.
Olsen TW. 8 questions with Dr. Puliafito. Ophthalmic Surg Lasers Imaging Retina
2013;44(4):424-5.
7.
Olsen TW (commentary): “Do you already recommend a supplement formulation that
includes lutein and Zeaxanthin in patients with macular degeneration?” and “Do you or
would you recommend . . . omega-3 . . for AMD . . .?” Ocular Surgery News Survey of
150+ Leading Retina Specialists (Chosen as the lead commentary: July 25, 2013 pp 28.
8.
Singer MA, Olsen TW, Lim JI, and Fine HF: Ocular Surgery News Survey of 150+ Leading
Retina Specialists (Chosen as the lead commentary of 3 opinions in this article: “In your
practice, do you diagnose retinal detachments using ultrasound?” March 25, 2013.
9.
Singer MA, Olsen TW, Lim JI, and Fine HF: Ocular Surgery News Survey of 150+ Leading
Retina Specialists (Chosen as the lead commentary of 3 opinions in this article: “Do you
perform pneumatic retinopexy as first line management for cases of primary retinal
detachment?” February 25, 2013.
10.
Olsen TW, Lim JI, and Freund KB: Ocular Surgery News Survey of 150+ Leading Retina
Specialists, Chosen as the lead commentary of 3 opinions in this article: “Do you perform
peripheral fluorescein angiography guided panretinal laser photocoagulation for ischemic
retinopathies (e.g. PDR or ischemic CRVO) or do you apply scatter laser in another way?”
October 25, 2012.
11.
Kim T, Olsen TW. Cataract Experts Share Their Surgical Mishaps. Case #13: It’s going,
going, gone . . . or maybe not. EYENET (AAO news publication). February 2012 pp 4462.
12.
Kaiser RS, Olsen TW, Freund KB, Gottlieb JL, Suner IJ; Spirin MJ & Regillo CD (eds):
Key Opinion Leaders Comment on: Diagnosis and Management of Retinal Vein Occlusions.
Retina Times, Spring 2009 pp 21-26.
13.
Olsen TW, Hartnett ME:
Consultants for Focal Points (Clinical Modules for
Ophthalmologists); Pharmacotherapy Targeting Ocular Neovascularization (Comments to
issues raised in the Review). American Academy of Ophthalmology; Volume XXVI, 7,
September 2008.
14.
Olsen TW: Drug Delivery to the Retina Using Intravitreal Aerosolized Nanoparticles.
Retina Physician, June, 2008, pp 26-32, 2008.
15.
Olsen TW: Drug Delivery to the Suprachoroidal Space Shows Promise: Retina Today,
March/April 2007; pp 36-39.
16.
Klesert TR, Section ed. Chang T, Ed.; Bovino JA, Harbour JW, Heier J, Olsen TW,
Pieramici D, Postel E, Schachat A, Shah GK. What is the Future for Academic Retina
Programs? Part 1. Key Opinion Leaders, Retina Times, Fall 2006, pp 22-27.
17.
Bressler NM, Klein ML, MacCumber MW, Mieler WF, Olsen TW. Case Studies: Current
and Future Treatment Options for Neovascular Age-Related Macular Degeneration.
Advanced Studies in Ophthalmology 2:3; December 2005 pp 113-120.
18.
Cunningham ET, Arroyo JG, Olsen TW, Regillo CD, Slakter JS. Round Table: Clinicans
Explore the latest results, outlook for photodynamic Therapy. Ocular Surgery News,
January 15, 2003.
19.
Olsen TW, Lim JI, Grossniklaus HE. Material Cristalino Retenido Que Semeja Un Tumor
Pigment Ado En Crecimiento Del Iris. Arch Ophthalmol Edición Española 8; 29-30, 1997.
20.
Olsen TW, Lim JI, Capone A, Myles RA, Gilman JP. Choque anafiláctico tras angiografía
con verde de indocianina. Arch Ophthalmol Edición Española 7; 149-50, 1996.
21.
Olsen TW, Benegas NM, Joplin AC, Evangelista A, Mindrup EA, Holland EJ. La
Rapamicina Inhibe El Rechazo Y La Neovascularización De Los Aloinjertos Corneales. Arch
Ophthalmol Edición Española 6; 68-72, 1995.